Scilex (SCLXW) Competitors $0.39 -0.01 (-2.50%) As of 09/12/2025 01:42 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock SCLXW vs. ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, AONCW, AONC, APLMW, and BIAFWShould you be buying Scilex stock or one of its competitors? The main competitors of Scilex include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), American Oncology Network (AONCW), American Oncology Network (AONC), Apollomics (APLMW), and bioAffinity Technologies (BIAFW). These companies are all part of the "medical" sector. Scilex vs. Its Competitors 180 Life Sciences 60 Degrees Pharmaceuticals Aclarion Ainos Alpha Tau Medical Alvotech American Oncology Network American Oncology Network Apollomics bioAffinity Technologies Scilex (NASDAQ:SCLXW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation and media sentiment. Does the media favor SCLXW or ATNFW? In the previous week, Scilex had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for Scilex and 0 mentions for 180 Life Sciences. Scilex's average media sentiment score of 1.91 beat 180 Life Sciences' score of 0.00 indicating that Scilex is being referred to more favorably in the media. Company Overall Sentiment Scilex Very Positive 180 Life Sciences Neutral Is SCLXW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets ScilexN/A N/A N/A 180 Life Sciences N/A N/A N/A Which has higher earnings and valuation, SCLXW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioScilex$44.24MN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A SummaryScilex beats 180 Life Sciences on 3 of the 3 factors compared between the two stocks. Get Scilex News Delivered to You Automatically Sign up to receive the latest news and ratings for SCLXW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SCLXW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCLXW vs. The Competition Export to ExcelMetricScilexDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$76.37B$5.84B$10.14BDividend YieldN/A2.44%5.68%4.60%P/E RatioN/A224.2775.4125.98Price / SalesN/A171.88515.81181.13Price / CashN/A17.5937.5660.44Price / BookN/A3.3112.156.29Net IncomeN/A$3.43B$3.29B$271.07M7 Day Performance-10.37%-2.20%0.73%3.87%1 Month Performance-7.50%-0.13%4.99%5.49%1 Year Performance30.04%7.21%62.53%25.86% Scilex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCLXWScilexN/A$0.39-2.5%N/A+30.0%$0.00$44.24M0.00105Positive NewsATNFW180 Life SciencesN/A$0.10-43.6%N/A+1,189.8%$0.00N/A0.007High Trading VolumeSXTPW60 Degrees PharmaceuticalsN/A$0.05-5.7%N/AN/A$0.00$641.41K0.002Positive NewsGap DownACONWAclarionN/A$0.03+12.0%N/A-12.9%$0.00$62.95K0.007Positive NewsGap DownAIMDWAinosN/A$0.11-18.3%N/AN/A$0.00$110.87K0.0040Positive NewsGap DownDRTSWAlpha Tau MedicalN/A$0.30+0.7%N/AN/A$0.00N/A0.0080Gap DownALVOWAlvotechN/A$0.96-15.0%N/A-62.4%$0.00$560.10M0.004News CoverageGap DownAONCWAmerican Oncology NetworkN/A$1.35-1.5%N/AN/A$0.00$1.34B0.001,525News CoveragePositive NewsShort Interest ↓Gap DownAONCAmerican Oncology NetworkN/A$11.00+0.1%N/A+201.4%$0.00$1.34B0.001,520News CoverageShort Interest ↑APLMWApollomicsN/A$0.02-3.2%N/A+68.9%$0.00N/A0.0059Short Interest ↓Gap DownBIAFWbioAffinity TechnologiesN/A$0.07+16.9%N/A-95.0%$0.00$7.68M0.0010Gap Up Related Companies and Tools Related Companies ATNFW Competitors SXTPW Competitors ACONW Competitors AIMDW Competitors DRTSW Competitors ALVOW Competitors AONCW Competitors AONC Competitors APLMW Competitors BIAFW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SCLXW) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredExpert Alert: Massive Bubble Could Crash Your WealthOn July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushin...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredChina’s message to TrumpDid China just fire shots at America? Last week, in Tiananmen Square, China put on a chilling display of mi...Porter & Company | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scilex Holding Please log in to your account or sign up in order to add this asset to your watchlist. Share Scilex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.